According to clinical data (amylase and CEA concentrations), samples were divided in two groups: benign cysts (PC, WOPN and SC) and premalignant cysts (IPMN and MCN). The gene discussed is CEACAM5; the disease is pancreatic intraductal papillary-mucinous neoplasm.